Boston Scientific: Endoluminal, full thickness tumor resection device
This project has been secured to protect intellectual property.
Login for More InformationThe objective is to design a device that can successfully resect stage 3 and 4 colorectal tumors from within the colon wall.
Project Overview
Later stages of colorectal cancer result in tumor development that advances deeper into the tissue of the gastrointestinal wall. As tumors penetrate deeper layers of the colon, their removal by traditional methods becomes increasingly difficult, and more advanced tumors increase rates of mortality and recurrence. If left untreated, a patient has a 65% chance of survival one year from its onset, and a 25% chance after two years due to the increasing chance of metastasis. In order to reduce cancer mortality by up to 50%, tumor removal is necessary. In conjunction with the rise of minimally invasive surgery, we will consider laparoscopic and other minimally invasive approaches upon designing the device. Since competing designs are still mainly tested on animal models in preclinical trials, a clear solution has yet to be widely available. Thus our client has asked us to address this market need by designing an endoluminal, full-thickness resection device that will remove stage 3 and stage 4 tumors located in the colon, while also connecting surrounding tissue together to close the colon wall.
Team Picture
Contact Information
Team Members
- Jacob Kocemba - Co-Team Leader
- Russell Heintz - Co-Team Leader
- Ben Bochenski - Communicator
- Caelie Raeburn - BSAC
- Adam Ebenhoeh - BWIG
- Logan Moller - BPAG
Advisor and Client
- Prof. Paul Campagnola - Advisor
- Carl Parent - Client
- Allie Levin - Alternate Contact
- Frank Deguire - Alternate Contact
- Ms. Lisa Shoemaker - Alternate Contact
Related Projects
- Fall 2023: Boston Scientific: Endoluminal, full thickness tumor resection device
- Spring 2023: Boston Scientific: Endoluminal, full thickness tumor resection device
- Fall 2022: Boston Scientific: Endoluminal, full thickness tumor resection device
- Spring 2022: Boston Scientific: Endoluminal, full thickness tumor resection device
- Fall 2021: Boston Scientific: Endoluminal, full thickness tumor resection device